Biological Quality In The Spotlight As UK MHRA Consults On Standard-Setting
Executive Summary
Quality standards for biological medicines are in the spotlight again, with the UK medicines regulator, the MHRA, in the midst of consulting stakeholders on how to ensure that publicly available monographs are suitable for biologicals in the future.